Trimetazidine Hydrochloride


Indications and Reactions:

Role Indications Reactions
Secondary
Drug Use For Unknown Indication 27.9%
Hypertension 18.9%
Type 2 Diabetes Mellitus 11.7%
Acute Myeloid Leukaemia 5.4%
Product Used For Unknown Indication 4.5%
Coronary Artery Disease 3.6%
Depression 3.6%
Medication Error 3.6%
Hypercholesterolaemia 2.7%
Hypersensitivity 2.7%
Osteoporosis 2.7%
Pain 2.7%
Chest Pain 1.8%
Osteoarthritis 1.8%
Pruritus 1.8%
Analgesic Intervention Supportive Therapy 0.9%
Angina Pectoris 0.9%
Antitussive Therapy 0.9%
Anxiety 0.9%
Cataplexy 0.9%
Hepatitis Cholestatic 10.0%
Aggression 6.7%
Hypothyroidism 6.7%
Oral Mucosa Erosion 6.7%
Orthostatic Hypotension 6.7%
Primary Hypogonadism 6.7%
Pruritus 6.7%
Tremor 6.7%
Vertigo 6.7%
Agitation 3.3%
Angiolymphoid Hyperplasia With Eosinophilia 3.3%
Cerebral Atrophy 3.3%
Fall 3.3%
Glycosylated Haemoglobin Increased 3.3%
Hypotonia 3.3%
Malaise 3.3%
Microcytic Anaemia 3.3%
Personality Change 3.3%
Renal Failure 3.3%
Retinopathy 3.3%
Concomitant
Drug Use For Unknown Indication 16.2%
Hypertension 14.2%
Product Used For Unknown Indication 10.3%
Coronary Artery Disease 6.8%
Type 2 Diabetes Mellitus 6.1%
Insulin-requiring Type 2 Diabetes Mellitus 5.5%
Rheumatoid Arthritis 5.0%
Hypercholesterolaemia 3.9%
Angina Pectoris 3.7%
Cardiac Failure 3.7%
Osteoporosis 3.7%
Cardiovascular Disorder 2.8%
Diabetes Mellitus 2.8%
Myocardial Ischaemia 2.8%
Depression 2.2%
Dyslipidaemia 2.2%
Atrial Fibrillation 2.0%
Benign Prostatic Hyperplasia 2.0%
Colorectal Cancer 2.0%
Prophylaxis 2.0%
Thrombocytopenia 19.7%
Osteonecrosis 6.6%
Renal Failure Acute 6.6%
Myocardial Infarction 5.3%
Pneumonia 5.3%
Pyrexia 5.3%
Somnolence 5.3%
Vomiting 5.3%
Hypokalaemia 3.9%
Oedema Peripheral 3.9%
Purpura 3.9%
Rectal Haemorrhage 3.9%
Renal Failure 3.9%
Toxic Skin Eruption 3.9%
Weight Decreased 3.9%
Angina Pectoris 2.6%
Death 2.6%
Dyspnoea 2.6%
Faecaloma 2.6%
Hypertension 2.6%

Drug Data